| Career trajectories of MD-PhD physician scientists: The loss of women investigators RA Steinman, LM Gandy, H Qi, EJ Fertig, AL Blackford, JR Grandis Cancer cell 42 (5), 723-726, 2024 | | 2024 |
| Ultrasound enhanced siRNA delivery using cationic liposome-microbubble complexes for the treatment of squamous cell carcinoma B Qin, X Chen, J Zhu, J Kopechek, B Helfield, F Yu, J Cyriac, L Lavery, ... Nanotheranostics 8 (3), 285, 2024 | | 2024 |
| Rare antibody phage isolation and discrimination (RAPID) biopanning enables identification of high-affinity antibodies against challenging targets D Chung, S Kong, NJ Young, SW Chuo, JV Shiah, EJ Connelly, ... Communications Biology 6 (1), 1036, 2023 | 1 | 2023 |
| To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer RH Lee, DE Johnson, JR Grandis Cancer research 83 (19), 3162-3164, 2023 | 1 | 2023 |
| New insights into RAS in head and neck cancer S Jagadeeshan, OZ Novoplansky, O Cohen, I Kurth, J Hess, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 188963, 2023 | | 2023 |
| Mutated HRAS activates YAP1–AXL signaling to drive metastasis of head and neck cancer S Jagadeeshan, M Prasad, M Badarni, T Ben-Lulu, VB Liju, ... Cancer research 83 (7), 1031-1047, 2023 | 9 | 2023 |
| Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts RH Lee, R Roy, H Li, A Hechmer, TR Zhu, A Izgutdina, AB Olshen, ... PloS one 18 (3), e0282177, 2023 | 1 | 2023 |
| Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit MA Mascarella, TF Olonisakin, P Rumde, V Vendra, MA Nance, S Kim, ... Clinical Cancer Research 29 (4), 723-730, 2023 | 2 | 2023 |
| Head and neck squamous cell carcinoma (vol 6, 92, 2020) DE Johnson, B Burtness, CR Leemans, VWY Lui, JE Bauman, JR Grandis NATURE REVIEWS DISEASE PRIMERS 9 (1), 2023 | | 2023 |
| Transcription factors and cancer: approaches to targeting JV Shiah, DE Johnson, JR Grandis The Cancer Journal 29 (1), 38-46, 2023 | 4 | 2023 |
| Author Correction: Head and neck squamous cell carcinoma DE Johnson, B Burtness, CR Leemans, VWY Lui, JE Bauman, JR Grandis Nature Reviews: Disease Primers 9 (1), 4, 2023 | 8 | 2023 |
| The mutational profiles and corresponding therapeutic implications of PI3K mutations in cancer NK VanLandingham, A Nazarenko, JR Grandis, DE Johnson Advances in biological regulation 87, 100934, 2023 | 5 | 2023 |
| The contemporary management of cancers of the sinonasal tract in adults R Thawani, MS Kim, A Arastu, Z Feng, MT West, NF Taflin, KZ Thein, R Li, ... CA: a cancer journal for clinicians 73 (1), 72-112, 2023 | 52 | 2023 |
| Cancer in 2022 LM Coussens, L Baezconde-Garbanati, AP Dicker, M Foti, M Fouladi, ... CANCER DISCOVERY 12 (12), 2733-2738, 2022 | 1 | 2022 |
| STAT3 activation as a predictive biomarker for ruxolitinib response in head and neck cancer Z Qureshy, H Li, Y Zeng, J Rivera, N Cheng, CN Peterson, MO Kim, ... Clinical Cancer Research 28 (21), 4737-4746, 2022 | 13 | 2022 |
| Correction: Cross-talk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer TM Brand, S Hartmann, NE Bhola, H Li, Y Zeng, RA O'Keefe, MV Ranall, ... Cancer Research 82 (17), 3187-3187, 2022 | 2 | 2022 |
| Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer TM Brand, S Hartmann, NE Bhola, H Li, Y Zeng, RA O'Keefe, MV Ranall, ... Cancer Research 82 (17), 3188-3188, 2022 | 1 | 2022 |
| Emerging tyrosine kinase inhibitors for head and neck cancer Z Long, JR Grandis, DE Johnson Expert opinion on emerging drugs 27 (3), 333-344, 2022 | 4 | 2022 |
| Gender equity in science and medicine: breaking the impasse JR Grandis Cancer Discovery, OF1-OF4, 2022 | 1 | 2022 |
| Classification and nomenclature of fibro-osseous lesions (vol 131, pg 385, 2021) AK El-Naggar, JKC Chan, JR Grandis, T Takata, PJ Slootweg ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY 133 (3), 358-358, 2022 | | 2022 |
